Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "epidermal gene expression regulator" refers to a set of molecules—primarily transcription factors and signaling pathways—that control the specific patterns of gene expression required for epidermal (skin) development, differentiation, and homeostasis. These regulators ensure that keratinocytes (the main cell type in the epidermis) proliferate, differentiate, and function properly. Key regulators include transcription factors like p63, AP-1, Ets, AP-2 families, and signaling pathways like the EGFR pathway. These components work together to control biological processes like ectoderm development, epidermal cell differentiation, and formation of the cornified envelope. Disruption of these regulators can lead to developmental defects or disease states such as cancer or skin barrier disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Gene Expression Regulator.